Non-muscle Invasive Bladder Cancer
Conditions
Brief summary
The aim is to evaluate and compare treatment strategies for non-muscle invasive bladder cancer. Furthermore, the impact of intravesical instillations on bladder function will be examined by urodynamic examination both prior to and following instillation therapy.
Interventions
A urodynamic examination is performed in all patients four to six weeks following TURBT and repeated six months later in order to obtain bladder function and possible changes.
Sponsors
Study design
Eligibility
Inclusion criteria
* non-muscle invasive bladder tumour
Exclusion criteria
* more than one previous bladder tumour recurrence * muscle invasive bladder cancer (at baseline or prior to inclusion) * utilization of urinary catheter * have had heart valve replacement performed * pregnant or lactating
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in urodynamic specifics (bladder compliance, detrusor overactivity, maximal cystometric capacity) | examined at time 0 and after six months | Obtained from the urodynamic test |
Countries
Denmark